Haleon plc (NYSE:HLN) Shares Bought by First Eagle Investment Management LLC

First Eagle Investment Management LLC lifted its stake in shares of Haleon plc (NYSE:HLN - Free Report) by 36.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,862,056 shares of the company's stock after buying an additional 501,035 shares during the quarter. First Eagle Investment Management LLC's holdings in Haleon were worth $15,381,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Personalized Indexing Management LLC raised its stake in shares of Haleon by 6.0% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 93,739 shares of the company's stock valued at $771,000 after purchasing an additional 5,347 shares during the period. Financial Advocates Investment Management lifted its holdings in Haleon by 18.5% in the 4th quarter. Financial Advocates Investment Management now owns 17,592 shares of the company's stock worth $145,000 after buying an additional 2,743 shares in the last quarter. Independent Advisor Alliance purchased a new position in Haleon in the 4th quarter valued at about $129,000. Brown Advisory Inc. grew its stake in shares of Haleon by 14.1% during the fourth quarter. Brown Advisory Inc. now owns 41,427 shares of the company's stock valued at $341,000 after acquiring an additional 5,104 shares in the last quarter. Finally, Coldstream Capital Management Inc. increased its position in shares of Haleon by 192.3% during the fourth quarter. Coldstream Capital Management Inc. now owns 36,888 shares of the company's stock worth $304,000 after acquiring an additional 24,270 shares during the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Stock Down 0.9 %

Shares of Haleon stock traded down $0.09 during trading on Thursday, reaching $10.46. The company had a trading volume of 4,324,377 shares, compared to its average volume of 4,945,940. The company has a market cap of $47.76 billion, a price-to-earnings ratio of 35.20, a price-to-earnings-growth ratio of 3.10 and a beta of 0.26. Haleon plc has a fifty-two week low of $7.70 and a fifty-two week high of $10.76. The firm's fifty day moving average is $9.70 and its 200-day moving average is $8.84. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.

Haleon (NYSE:HLN - Get Free Report) last released its earnings results on Thursday, August 1st. The company reported $0.08 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.01). Haleon had a return on equity of 13.15% and a net margin of 9.71%. The firm had revenue of $3.50 billion for the quarter, compared to the consensus estimate of $3.55 billion. During the same period in the prior year, the business earned $0.08 EPS. On average, analysts anticipate that Haleon plc will post 0.46 EPS for the current year.

Haleon Cuts Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Thursday, September 19th. Shareholders of record on Friday, August 16th will be paid a dividend of $0.0514 per share. The ex-dividend date is Friday, August 16th. This represents a yield of 1.6%. Haleon's payout ratio is 33.33%.

Analysts Set New Price Targets

A number of brokerages recently commented on HLN. The Goldman Sachs Group downgraded Haleon from a "buy" rating to a "neutral" rating in a report on Tuesday, August 6th. Berenberg Bank began coverage on shares of Haleon in a research report on Tuesday, August 6th. They set a "buy" rating for the company. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy".

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.